Indivior Pharmaceuticals (INDV) Return on Capital Employed (2024 - 2026)

Indivior Pharmaceuticals' Return on Capital Employed history runs 3 years deep, the most recent figure standing at 79.29% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 7077.0% year-over-year to 79.29%; the TTM figure through Mar 2026 stood at 79.29% (up 7077.0% YoY), while the FY2025 annual figure was 76.05%, up 6985.0% from the prior year.
• Return on Capital Employed was 79.29% for Q1 2026 at Indivior Pharmaceuticals, up from 66.41% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 79.29% in Q1 2026 to a low of 6.14% in Q4 2024.
• Historically, Return on Capital Employed has averaged 45.0% across 3 years, with a median of 54.83% in 2025.
• The sharpest annual moves came in 2025 and 2026: Return on Capital Employed jumped 6027 bps in 2025, then soared 7077 bps in 2026.
• A 3-year view of Return on Capital Employed shows it stood at 6.14% in 2024, then jumped by 981 bps to 66.41% in 2025, then climbed by 19 bps to 79.29% in 2026.
• The last three Return on Capital Employed figures came in at 79.29% (Q1 2026), 66.41% (Q4 2025), and 48.4% (Q3 2025), per Business Quant data.